Pilati, Camilla

Immune and stromal classification of colorectal cancer is associated with molecular subtypes and relevant for precision immunotherapy

Becht, E., de Reyniès, A., Giraldo, N. A., Pilati, C., Buttard, B., Lacroix, L., Selves, J., Sautès-Fridman, C., Laurent-Puig, P., & Fridman, W. H. (2016) · Clinical Cancer Research

Colorectal Cancer Treatments and StudiesCancer Immunotherapy and Biomarkers

Cited by 590

Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas

Nault, J.-C., Datta, S., Imbeaud, S., Franconi, A., Mallet, M., Couchy, G., Letouzé, E., Pilati, C., Verret, B., Blanc, J.-F., et al. (2015) · Nature Genetics

Virus-based gene therapy researchCancer Genomics and Diagnostics

Cited by 489

Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours

Rebouissou, S., Amessou, M., Couchy, G., Poussin, K., Imbeaud, S., Pilati, C., Izard, T., Balabaud, C., Bioulac-Sage, P., & Zucman-Rossi, J. (2009) · Nature

Cytokine Signaling Pathways and InteractionsLiver physiology and pathology

Cited by 477

Mutational signature analysis identifies MUTYH deficiency in colorectal cancers and adrenocortical carcinomas

Pilati, C., Shinde, J., Alexandrov, L. B., Assié, G., André, T., Hélias‐Rodzewicz, Z., Ducoudray, R., Le Corre, D., Zucman‐Rossi, J., Emile, J., et al. (2017) · The Journal of Pathology

Genetic factors in colorectal cancerCancer Genomics and Diagnostics

Cited by 150

Intratumor CMS heterogeneity impacts patient prognosis in localized colon cancer

Marisa, L., Blum, Y., Taieb, J., Ayadi, M., Pilati, C., Le Malicot, K., Lepage, C., Salazar, R., Aust, D., Duval, A., et al. (2021) · Clinical Cancer Research

Colorectal Cancer Treatments and StudiesGenetic factors in colorectal cancer

Cited by 68

Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis

Lawlor, R. T., Veronese, N., Pea, A., Nottegar, A., Smith, L., Pilati, C., Demurtas, J., Fassan, M., Cheng, L., & Luchini, C. (2019) · BMC Cancer

Telomeres, Telomerase, and SenescenceSarcoma Diagnosis and Treatment

Cited by 62

The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancer

Le Corre, D., Ghazi, A., Balogoun, R., Pilati, C., Aparicio, T., Martin-Lannerée, S., Marisa, L., Djouadi, F., Poindessous, V., Crozet, C., et al. (2019) · eBioMedicine

Cancer Cells and MetastasisColorectal Cancer Treatments and Studies

Cited by 48

Beyond KRAS Status and Response to Anti-EGFR Therapy in Metastatic Colorectal Cancer

Perkins, G., Pilati, C., Blons, H., & Laurent-Puig, P. (2014) · Pharmacogenomics

Colorectal Cancer Treatments and StudiesLung Cancer Treatments and Mutations

Cited by 22

Prognostic value of the PrP C -ILK-IDO1 axis in the mesenchymal colorectal cancer subtype

Ghazi, A., Le Corre, D., Pilati, C., Taieb, J., Aparicio, T., Didelot, A., Dedhar, S., Mulot, C., Le Malicot, K., Djouadi, F., et al. (2021) · OncoImmunology

Colorectal Cancer Treatments and StudiesCancer Cells and Metastasis

Cited by 21

A proof of concept for targeting the PrPC - Amyloid β peptide interaction in basal prostate cancer and mesenchymal colon cancer

Mouillet-Richard, S., Martin-Lannerée, S., Le Corre, D., Hirsch, T. Z., Ghazi, A., Sroussi, M., Pilati, C., de Reyniès, A., Djouadi, F., Vodovar, N., et al. (2022) · Oncogene

Prion Diseases and Protein MisfoldingAlzheimer's disease research and treatments

Cited by 14